1. Home
  2. CCRN vs STOK Comparison

CCRN vs STOK Comparison

Compare CCRN & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • STOK
  • Stock Information
  • Founded
  • CCRN 1986
  • STOK 2014
  • Country
  • CCRN United States
  • STOK United States
  • Employees
  • CCRN N/A
  • STOK N/A
  • Industry
  • CCRN Professional Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCRN Consumer Discretionary
  • STOK Health Care
  • Exchange
  • CCRN Nasdaq
  • STOK Nasdaq
  • Market Cap
  • CCRN 447.2M
  • STOK 517.0M
  • IPO Year
  • CCRN N/A
  • STOK 2019
  • Fundamental
  • Price
  • CCRN $13.18
  • STOK $9.54
  • Analyst Decision
  • CCRN Hold
  • STOK Strong Buy
  • Analyst Count
  • CCRN 5
  • STOK 5
  • Target Price
  • CCRN $17.93
  • STOK $24.50
  • AVG Volume (30 Days)
  • CCRN 248.8K
  • STOK 694.7K
  • Earning Date
  • CCRN 05-07-2025
  • STOK 05-13-2025
  • Dividend Yield
  • CCRN N/A
  • STOK N/A
  • EPS Growth
  • CCRN N/A
  • STOK N/A
  • EPS
  • CCRN N/A
  • STOK 0.88
  • Revenue
  • CCRN $1,258,238,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • CCRN N/A
  • STOK $44.17
  • Revenue Next Year
  • CCRN $5.37
  • STOK $20.00
  • P/E Ratio
  • CCRN N/A
  • STOK $10.88
  • Revenue Growth
  • CCRN N/A
  • STOK 2333.81
  • 52 Week Low
  • CCRN $9.58
  • STOK $5.35
  • 52 Week High
  • CCRN $18.50
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 23.59
  • STOK 54.33
  • Support Level
  • CCRN $13.81
  • STOK $9.09
  • Resistance Level
  • CCRN $13.96
  • STOK $9.83
  • Average True Range (ATR)
  • CCRN 0.34
  • STOK 0.62
  • MACD
  • CCRN -0.03
  • STOK -0.05
  • Stochastic Oscillator
  • CCRN 2.41
  • STOK 48.19

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: